Boston — Boston, Massachusetts

Boston is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Boston has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Non-infectious Anterior Uveitis, Uveitic Glaucoma.

Sponsors: Finch Research and Development LLC., Tarsier Pharma, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston?

Boston has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston conducted?

Boston has 7 clinical trials on record, with 2 currently active. Their work covers Clostridium Difficile Infection Recurrence, Non-infectious Anterior Uveitis, Uveitic Glaucoma.

Is Boston accredited by Crixeo Clinical Trials?

Boston has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.